COMPANY INTELLIGENCE PROFILE
CLARITRICS INDIA PRIVATE LIMITED
Claritrics India Private Limited is the Chennai-based Indian delivery/operations subsidiary of Claritrics Inc.
Claritrics India Private Limited, established on June 12, 2018, is a Chennai-based subsidiary of Claritrics Inc. (BUDDI.AI) specializing in healthcare revenue cycle management and medical coding automation. Despite achieving a revenue growth of 12.35% with Rs 25, 50 crore for FY2023, the company recorded a net loss with a profit margin of -2.01% and a significant increase in borrowings. Legal matters include tax disputes in Indian courts.
AI-generated, may contain errors.
Business Overview
- Claritrics India Private Limited is the Chennai-based Indian delivery/operations subsidiary of Claritrics Inc. (New York, USA), which trades under the consumer brand "BUDDI.AI." The group builds a deep-learning/AI platform automating healthcare revenue-cycle management — autonomous medical coding, claim-denial prevention, clinical documentation improvement, patient registration, billing automation and prior-authorization processing — serving US healthcare providers, payers and health information exchanges.
- Founded in 2013 by Ram (Ramachandran) Swaminathan, Sudarsun Santhiappan and Venkatesh Prabhu (Gopalan)
- Platform is described as HIPAA/SOC 2 compliant, deployed on Microsoft Azure, with an IIT-Madras research partnership.
- Confirmed: the corporate website claritrics.com 301-redirects to buddi.ai — same operating entity, brand renamed to BUDDI.AI, source: direct fetch + DuckDuckGo snippets citing Dealroom/Crunchbase "legally known as Claritrics Inc.".
Sector & Classification
Business Process Outsourcing / IT-enabled services — "Other information & communication service activities; back-office operations including insurance claim services and medical transcription services" (Tofler/TheCompanyCheck). NIC-code business line: healthcare RCM (revenue cycle management) and medical coding automation.
Directors & Key Management
Directors — source notes
Current (per TheCompanyCheck, appointment dates shown; DINs per Tofler): - Ramachandran Swaminathan — DIN 06817363 — director since 29 Mar 2019 (co-founder) - Malathi Swaminathan — DIN 08246975 — director since 02 Sep 2024 (also director of group companies Claritrics Technologies Pvt Ltd and Pranhaa 23 Pvt Ltd — confirmed by 2 sources) Note/possible former director: one DuckDuckGo-surfaced snippet (source page unclear) names "Venkatesh Prabhu Gopalan" (co-founder) as a director alongside Ramachandran Swaminathan; this conflicts with the more current Tofler/TheCompanyCheck director list and could not be corroborated with a DIN or confirmed dated source — flagged as unconfirmed/possibly a past directorship, not included as a current director.
GST Registrations
Primary GSTIN: 33AAHCC6213H1ZZ (Tamil Nadu, state code 33) — registered 09 Feb 2019, Regular taxpayer, Active. PAN AAHCC6213H matches company PAN (Tofler) — no entity-confusion risk. One additional GSTIN found: 07AAHCC6213H1ZU (Delhi, state code 07) — status Cancelled. Total registrations found: 2 (1 active, 1 cancelled). Home state: Tamil Nadu.
Financials
CLARITRICS INDIA PRIVATE LIMITED experienced 12.35% year-over-year revenue growth in FY2023, with EBITDA improving by 43.76%. However, PAT declined by 25.78%, leading to a net profit margin of -2.01%. Net worth increased by 48.33%, but total borrowings surged by 1024.91%, resulting in a debt-to-equity ratio of 2.29 and a negative ROE of -32.54%. The company shows revenue growth and EBITDA improvement but struggles with net losses and increased leverage.
AI-generated, may contain errors.
| Latest audited FY referenced | FY2023, year ended March 2023, standalone basis (Tofler). |
| Revenue | Rs 25–50 crore band, Tofler operating-revenue range, +12.35% YoY — exact figure paywalled, "not obtained" precisely |
| EBITDA | exact figure paywalled; +43.76% YoY |
| PAT | declined -25.78% YoY; net profit margin -2.01%, loss-making on this metric |
| Net worth | +48.33% YoY, exact figure not obtained |
| Total borrowings | +1024.91% YoY; debt-to-equity 2.29; ROE -32.54% |
| AGM | 21 Dec 2024; balance sheet filed as of 31 Mar 2024, InstaFinancials |
| Overall picture | growing revenue, improving EBITDA, but a net loss and sharply higher leverage in FY23 — precise Rs-crore figures not obtained, behind Tofler Pro paywall |
| No Screener/Moneycontrol data available since the company is private/unlisted. | |
Funding History
- No India-entity-specific funding round found, this is an operating subsidiary, not typically a separate fundraising vehicle.
- At the parent, Claritrics Inc./BUDDI.AI, US, level: Tracxn/Crunchbase/Dealroom show one recorded early round — ~$201,000, Venture (series unknown), dated 15 Sep 2013, investors including Bluehill VC and Keiretsu Forum, 4 investors total, 2 unnamed.
- Separately, "ASA Capital acquired BUDDI AI, Claritrics Inc.," in 2020 per a Dealroom-indexed listing (dealert.ai) — deal size not disclosed in any source checked.
- Round names only, per Tracxn-sourcing rule
- Treat as parent-company/indicative, not confirmed India-entity funding.
Loans & Charges
- One open charge found (Tofler): HDFC Bank Limited — Rs 2.0 crore — charge created 19 Jan 2023. No other charges located.
Legal & Compliance
- Indian Kanoon — two matters found naming the company as party:
- 1. Claritrics India Private Limited vs The Assistant Commissioner (ST), Madras High Court, order dated 04 Sep 2024, Justice Krishnan Ramasamy, — a GST/sales-tax dispute
- Company represented by Director Ramachandran Swaminathan.
- 2. Claritrics India Private Limited vs DCIT, Corporate Circle 1 (1), Chennai — Income Tax Appellate Tribunal, Chennai, dated 04 Aug 2025, Assessment Year 2021-22 — company as appellant.
- No other litigation found.
Competitive Landscape
- AI-driven medical coding / healthcare RCM automation peers, buddi.ai's actual competitive set:
- Fathom Health (US) — autonomous medical coding, claims millions of charts/day processed — similar/larger scale
- Nym Health (US/Israel) — autonomous AI medical coding engine — similar scale
- CodaMetrix (US) — AI autonomous coding platform backed by major US health systems — larger scale
- 3M Health Information Systems (US) — legacy/incumbent computer-assisted coding vendor — much larger, established incumbent
- R1 RCM / Optum360 (US) — large-scale healthcare revenue-cycle BPO/tech providers — much larger scale
- Indian RCM/medical-coding BPO peers for context: Omega Healthcare, AGS Health, both Indian-origin healthcare RCM/BPO firms, — comparable or larger scale in the India-delivery RCM space
Frequently Asked Questions
What does Claritrics India Private Limited do?
Claritrics India Private Limited is the Chennai-based subsidiary of Claritrics Inc., trading under the consumer brand BUDDI.AI. The company builds a deep-learning and AI platform automating healthcare revenue cycle management, including medical coding, claim denial prevention, clinical documentation improvement, and more.
What is the incorporation date of Claritrics India Private Limited?
Claritrics India Private Limited was incorporated on 12 June 2018.
What is the CIN of Claritrics India Private Limited?
The Corporate Identification Number (CIN) of Claritrics India Private Limited is U72200TN2018PTC123179.
What is the GSTIN of Claritrics India Private Limited?
The primary GSTIN of Claritrics India Private Limited is 33AAHCC6213H1ZZ, registered in Tamil Nadu. An additional GSTIN in Delhi, 07AAHCC6213H1ZU, has been cancelled.
Where is the registered office of Claritrics India Private Limited located?
The registered office of Claritrics India Private Limited is located at 46/50, Indira Nagar Main Road, Opposite Ann Hospital, Valasaravakkam, Chennai, Tamil Nadu 600087.
Sources
Tofler (tofler.in) — identity, capital, directors/DINs, financial YoY %, charges, group-network; TheCompanyCheck (thecompanycheck.com) — identity, capital, director appointment dates, parent-company note; Falconebiz (falconebiz.com) — attempted, blocked by anti-bot/CAPTCHA gate on both direct URL guesses, no data extracted; DuckDuckGo-indexed snippets from ZaubaCorp, Tracxn, InstaFinancials, CrediHive, Economic Times, IndiaFilings, Dealroom, Crunchbase, LinkedIn, dealert.ai (funding/parent-company cross-checks — used only for named facts, not as primary registry source); Indian Kanoon (indiankanoon.org) — litigation; buddi.ai and claritrics.com — official site, redirect confirmation, logo asset (fetched directly via curl, HTTP 200 confirmed).
Information compiled from public registry and secondary sources. It may be incomplete or dated; verify independently before relying on it.